Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension
about
Heart failure with preserved ejection fraction: emerging drug strategiesTargeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseasePerivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension.Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation.Emerging translational approaches to target STAT3 signalling and its impact on vascular diseaseContext-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cellsInterleukin-10 protects against aging-induced endothelial dysfunction.Protective role of IL-6 in vascular remodeling in Schistosoma pulmonary hypertension.STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential.Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.Off-Target Vascular Effects of Cholesteryl Ester Transfer Protein Inhibitors Involve Redox-Sensitive and Signal Transducer and Activator of Transcription 3-Dependent Pathways.IL-6/STAT3 signaling in mice with dysfunctional type-2 ryanodine receptor.Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature.Genetic Interference With Endothelial PPAR-γ (Peroxisome Proliferator-Activated Receptor-γ) Augments Effects of Angiotensin II While Impairing Responses to Angiotensin 1-7.Interleukin 22 Promotes Blood Pressure Elevation and Endothelial Dysfunction in Angiotensin II-Treated Mice.Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs
P2860
Q24595118-19F03040-5DBC-409D-8419-1FD0B5C30D34Q26750725-A556BE9D-B925-4D72-AEEF-9DBC0EFB668BQ30830179-C622579A-80A3-4E8D-B97C-2D7707EA8038Q34419313-5F9926A1-B7AE-421B-837D-5B9CCD8FBE93Q35580177-7E11322C-778C-4FEB-BB70-B5211A46D948Q37139653-C8855225-B164-4BDB-A124-3FA0BFD5B681Q37411080-BF9C0FF0-3037-4C8A-BDCB-B26AC28652BFQ37596479-CDA6545B-924E-4C8C-A145-A6E1312A3799Q38647432-4FF43118-BEF7-4D51-AC3C-8CFAEC34058DQ39116577-829BF96E-65BA-4F41-BB96-A13E52C5AE85Q39949201-D59BAC31-6378-44E6-A95F-4E7F890DDCBCQ41222591-0315C930-4A23-45EB-8A1B-9C2D592B7416Q46252086-DB36F1C0-5A00-41B8-954C-F482AC0D3B66Q47710820-842863F8-E7B2-4CCA-A6BB-60827290BFB3Q48641988-C5F46F84-3C4D-4EA5-98A3-60D8A4618645Q57072670-2FB57F57-1A3D-47CA-8652-6266C7D54881
P2860
Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Small-molecule inhibitors of s ...... r dysfunction and hypertension
@ast
Small-molecule inhibitors of s ...... r dysfunction and hypertension
@en
type
label
Small-molecule inhibitors of s ...... r dysfunction and hypertension
@ast
Small-molecule inhibitors of s ...... r dysfunction and hypertension
@en
prefLabel
Small-molecule inhibitors of s ...... r dysfunction and hypertension
@ast
Small-molecule inhibitors of s ...... r dysfunction and hypertension
@en
P2093
P2860
P1433
P1476
Small-molecule inhibitors of s ...... r dysfunction and hypertension
@en
P2093
Andrew W Johnson
Dale A Kinzenbaw
Frank M Faraci
Mary L Modrick
P2860
P304
P356
10.1161/HYPERTENSIONAHA.111.00299
P407
P577
2012-12-24T00:00:00Z